Clinical Trial Detail

NCT ID NCT00375674
Title A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Recruitment Completed
Gender both
Phase
Variant Requirements no
Sponsors Pfizer
Indications

kidney cancer

Therapies

Sunitinib

Age Groups: adult

No variant requirements are available.